In the present article, we aimed to validate the efficacy of carbazole alkaloids (MHCs) through molecular docking and to delineate the mechanistic action of these compounds against p105, a transcription factor governing the NF-kB over-expression in breast cancer. This evidence concerns the gene NFKB1 and breast cancer.